We used liposomal amphotericin B as first-choice treatment of visceral leishmaniasis in 106 immunocompetent children who acquired the infection in a temperate region of southern Europe (Italy) where Leishmania infantum visceral leishmaniasis is endemic. The aim of the study was to identify the minimum total dose of liposomal amphotericin B needed to cure the infection in children and reduce the period of hospitalization. We conclude that the optimal regimen in immunocompetent children with L. infantum visceral leishmaniasis to be a total dose of 18 mg/kg of liposomal amphotericin B (3 mg/kg per day for 5 days, followed by 3 mg/kg administered as an outpatient regimen on day 10).

DI MARTINO L, DAVIDSON R.N, GIACCHINO R, SCOTTI S, RAIMONDI F, CASTAGNOLA E, et al. (1997). TREATMENT OF VISCERAL LEISHMANIASIS IN CHILDREN USING LIPOSOMAL AMPHOTHERICIN B. THE JOURNAL OF PEDIATRICS, 131, 271-277.

TREATMENT OF VISCERAL LEISHMANIASIS IN CHILDREN USING LIPOSOMAL AMPHOTHERICIN B

A. CASCIO;
1997-01-01

Abstract

We used liposomal amphotericin B as first-choice treatment of visceral leishmaniasis in 106 immunocompetent children who acquired the infection in a temperate region of southern Europe (Italy) where Leishmania infantum visceral leishmaniasis is endemic. The aim of the study was to identify the minimum total dose of liposomal amphotericin B needed to cure the infection in children and reduce the period of hospitalization. We conclude that the optimal regimen in immunocompetent children with L. infantum visceral leishmaniasis to be a total dose of 18 mg/kg of liposomal amphotericin B (3 mg/kg per day for 5 days, followed by 3 mg/kg administered as an outpatient regimen on day 10).
DI MARTINO L, DAVIDSON R.N, GIACCHINO R, SCOTTI S, RAIMONDI F, CASTAGNOLA E, et al. (1997). TREATMENT OF VISCERAL LEISHMANIASIS IN CHILDREN USING LIPOSOMAL AMPHOTHERICIN B. THE JOURNAL OF PEDIATRICS, 131, 271-277.
File in questo prodotto:
File Dimensione Formato  
Treatment of visceral leishmaniasis in children with liposomal amphotericin B.pdf

Solo gestori archvio

Tipologia: Post-print
Dimensione 1.31 MB
Formato Adobe PDF
1.31 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/415811
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 69
  • ???jsp.display-item.citation.isi??? ND
social impact